256 related articles for article (PubMed ID: 10791213)
1. Effects of prostaglandin E1 administration during hepatectomy for cirrhotic hepatocellular carcinoma.
Hanazaki K; Kajikawa S; Fujimori Y; Nakata S; Shimozawa N; Koide N; Adachi W; Amano J
Hepatogastroenterology; 2000; 47(32):461-4. PubMed ID: 10791213
[TBL] [Abstract][Full Text] [Related]
2. Administration of prostaglandin E1 reduces post-operative hepatocellular damage and restores hepatic integrity in patients undergoing hepatectomy.
Baek Y; Nakano H; Kumada K; Nagasaki H; Kigawa G; Sasaki J; Kaneda M; Hatakeyama T; Kitamura N; Sanada Y; Midorikawa T; Yamaguchi M
Hepatogastroenterology; 1999; 46(27):1836-41. PubMed ID: 10430356
[TBL] [Abstract][Full Text] [Related]
3. [Perioperative administration of prostaglandin E1 inhibits post-operative serum bilirubin increase and preserves prothrombin time in patients with hepatocellular carcinoma and cirrhosis after laparoscopic microwave coagulation therapy].
Miura Y; Nunokawa H; Iizawa K; Tanaka H; Shinzawa H
Masui; 2007 Jun; 56(6):671-6. PubMed ID: 17571606
[TBL] [Abstract][Full Text] [Related]
4. Is resection for large hepatocellular carcinoma in cirrhotic patients beneficial? Study of 38 cases.
Abdel-Wahab M; Sultan A; el-Ghawalby A; Fathy O; el-Ebidy G; Abo-Zeid M; Aboel-Enin A; Abdallah T; Fouad A; el-Fiky A; Gadel-Hak N; Ezzat F
Hepatogastroenterology; 2001; 48(39):757-61. PubMed ID: 11462920
[TBL] [Abstract][Full Text] [Related]
5. Splenic arterial ligation prevents liver injury after a major hepatectomy by a reduction of surplus portal hypertension in hepatocellular carcinoma patients with cirrhosis.
Sato Y; Kobayashi T; Nakatsuka H; Yamamoto S; Oya H; Watanabe T; Hatakeyama K
Hepatogastroenterology; 2001; 48(39):831-5. PubMed ID: 11462934
[TBL] [Abstract][Full Text] [Related]
6. Application of hemihepatic vascular occlusion with hanging maneuver in hepatectomy.
Wen Y; Miao X; Xiong L; Xiong G; Hu J; Zhong D; Li Q; Liu W
Hepatogastroenterology; 2009; 56(90):442-6. PubMed ID: 19579617
[TBL] [Abstract][Full Text] [Related]
7. Hepatic resection for hepatocellular carcinoma in severely cirrhotic livers.
Kaibori M; Matsui Y; Kitade H; Kwon AH; Kamiyama Y
Hepatogastroenterology; 2003; 50(50):491-6. PubMed ID: 12749254
[TBL] [Abstract][Full Text] [Related]
8. The effect of intraportal administration of prostaglandin E1 on liver blood flow and liver function.
Inagaki H; Kurokawa T; Nonami T; Miwa T; Nakao A; Takagi H
Hepatogastroenterology; 1999; 46(29):2909-13. PubMed ID: 10576371
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of hepatic arterial infusion of prostaglandin E1 in the treatment of postoperative acute liver failure--report of a case.
Sato T; Asanuma Y; Hashimoto M; Heianna J; Kusano T; Kurokawa T; Yasui O; Koyama K
Hepatogastroenterology; 2000; 47(33):846-50. PubMed ID: 10919045
[TBL] [Abstract][Full Text] [Related]
10. [Role of united hepatectomy and splenectomy in the surgical treatment of hepatocellular carcinoma complicated with hepatic cirrhosis and hypersplenism].
Chen XP; Wu ZD; Qiu FZ
Zhonghua Wai Ke Za Zhi; 2005 Apr; 43(7):442-6. PubMed ID: 15854370
[TBL] [Abstract][Full Text] [Related]
11. [Effect of prostaglandin E1 on arterial ketone body ratio during and after hepatectomy].
Nakayama M; Kanaya N; Fujita S; Kawana S; Namiki A
Masui; 1995 Sep; 44(9):1224-7. PubMed ID: 8523654
[TBL] [Abstract][Full Text] [Related]
12. Hepatic resection in cirrhotic liver for treatment of hepatocellular carcinoma in Egyptian patients. Experience with 140 cases in a single center.
Abdel Wahab M; Sultan A; el-Ghawalby N; Fathy O; Abu Zeid M; Abu el-Enin A; Abdallah T; Foad A; Kandeel T; el-Shobari M; el-Fiky A; el-Ebidy G; Gadel Hak N; Ezzat F
Hepatogastroenterology; 2004; 51(56):559-63. PubMed ID: 15086202
[TBL] [Abstract][Full Text] [Related]
13. Arterial ketone body ratio during hepatectomy.
Hanazaki K; Wakabayashi M; Sodeyama H; Sode Y; Kawamura N; Miyazaki T; Ohtsuka M
Hepatogastroenterology; 1997; 44(17):1438-44. PubMed ID: 9356869
[TBL] [Abstract][Full Text] [Related]
14. Limits and benefits of exclusive transthoracic hepatectomy approach for patients with hepatocellular carcinoma.
Pocard M; Sauvanet A; Regimbeau JM; Duwat O; Farges O; Belghiti J
Hepatogastroenterology; 2002; 49(43):32-5. PubMed ID: 11941979
[TBL] [Abstract][Full Text] [Related]
15. Hepatic resection for hepatocellular carcinoma existing with liver cirrhosis.
Ezaki T; Yamamoto K; Yamaguchi H; Sasaki Y; Ishida T; Mori M; Aimitsu S
Hepatogastroenterology; 2002; 49(47):1363-8. PubMed ID: 12239943
[TBL] [Abstract][Full Text] [Related]
16. [Improved kidney function with intravenous prostaglandin E1 in patients with terminal heart failure].
Wutte M; Hülsmann M; Berger R; Rödler S; Frey B; Stanek B; Pacher R
Wien Klin Wochenschr; 1998 Jul; 110(13-14):473-8. PubMed ID: 9746960
[TBL] [Abstract][Full Text] [Related]
17. Topical cooling-assisted hepatic segmentectomy for cirrhotic liver with hepatocellular carcinoma.
Yamanaka N; Furukawa K; Tanaka T; Tanaka W; Yamanaka J; Imakita M; Okamoto E
J Am Coll Surg; 1997 Mar; 184(3):290-6. PubMed ID: 9060927
[TBL] [Abstract][Full Text] [Related]
18. Measurement of portal venous pressure is useful for selecting the optimal type of resection in cirrhotic patients with hepatocellular carcinoma.
Kanematsu T; Furui J; Yanaga K; Okudaira S; Kamohara Y; Eguchi S
Hepatogastroenterology; 2005; 52(66):1828-31. PubMed ID: 16334786
[TBL] [Abstract][Full Text] [Related]
19. Preoperative estimation of surgical risk of hepatectomy in cirrhotic patients.
Noguchi T; Imai T; Mizumoto R
Hepatogastroenterology; 1990 Apr; 37(2):165-71. PubMed ID: 2160419
[TBL] [Abstract][Full Text] [Related]
20. Autologous blood transfusion for hepatectomy in patients with cirrhosis and hepatocellular carcinoma: use of recombinant human erythropoietin.
Kajikawa M; Nonami T; Kurokawa T; Hashimoto S; Harada A; Nakao A; Takagi H
Surgery; 1994 Jun; 115(6):727-34. PubMed ID: 8197566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
